Global Cancer Drugs Market Set for Rapid Growth, to Reach around USD 161.30 Billion by 2021

Some of the major companies in cancer drugs market comprise GlaxoSmithKline, Bayer, Sanofi, Novartis, Amgen, Pfizer, Bristol-Myers Squibb, Merck, Ariad Pharmaceuticals, Celgene Corporation, Hoffmann-La Roche Ltd, Eli Lilly, Johnson and Johnson, Boehringer Ingelheim GmbH, and Teva Pharmaceuticals among others. These players are ready to place the cancer drugs market on new heights.

As per analysts at Zion Market Research, the global cancer drugs market was capitalized at almost USD 112.90 Billion in 2015 and is anticipated to create income of almost USD 161.30 Billion by 2021, developing at a CAGR of almost 7.4% from 2016 to 2021.

Get Free Sample Of Report – https://www.zionmarketresearch.com/sample/cancer-drugs-market

North America Likely To Stay The Dominating Area In The Global Cancer Drugs Market In The Years To Come

Europe, North America, Latin America, Asia-Pacific, and the Middle East & Africa are major regional sections in the global cancer drugs market. North America is likely to stay the dominating area in the years to come. Requirement for cancer drugs was uppermost in North America particularly in the U.S. Therefore, Asia Pacific is likely to be the moderate developing area in cancer drugs market in the years to come. In addition to this, the Latin America and Middle East & Africa are also likely to display moderate development for cancer drugs market in the coming years.

The global cancer drugs market is segmented as follows:

By Therapy

• Immunotherapy
• Targeted Therapy
• Chemotherapy
• Hormone Therapy
• Others

By Application

• Breast Cancer
• Blood Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Skin Cancer
• Lung Cancer
• Others

By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

To view TOC of this report – https://www.zionmarketresearch.com/toc/cancer-drugs-market